Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
by from Morbidity and Mortality Weekly Report (MMWR) on (#6TE2X)
This report describes CDC's updated pneumococcal conjugate vaccine recommendation for all adults aged >=50 years who are PCV-naive or who have unknown vaccination history.